These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10861282)
1. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Brown MA; Edwards S; Hoyle E; Campbell S; Laval S; Daly AK; Pile KD; Calin A; Ebringer A; Weeks DE; Wordsworth BP Hum Mol Genet; 2000 Jul; 9(11):1563-6. PubMed ID: 10861282 [TBL] [Abstract][Full Text] [Related]
2. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Beyeler C; Armstrong M; Bird HA; Idle JR; Daly AK Ann Rheum Dis; 1996 Jan; 55(1):66-8. PubMed ID: 8572738 [TBL] [Abstract][Full Text] [Related]
3. Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls. Erden G; Acar FS; Inal EE; Soydas AO; Ozoran K; Bodur H; Yildirimkaya MM Rheumatol Int; 2009 Oct; 29(12):1431-4. PubMed ID: 19242697 [TBL] [Abstract][Full Text] [Related]
4. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228 [TBL] [Abstract][Full Text] [Related]
5. Association of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis. Mahmoudi M; Amirzargar AA; Jamshidi AR; Farhadi E; Noori S; Avraee M; Nazari B; Nicknam MH Eur Cytokine Netw; 2011 Dec; 22(4):175-80. PubMed ID: 22285486 [TBL] [Abstract][Full Text] [Related]
6. The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis. Brown MA; Rudwaleit M; Pile KD; Kennedy LG; Shatford J; Amos CI; Siminovitch K; Rubin L; Calin A; Wordsworth BP Br J Rheumatol; 1998 Apr; 37(4):454-8. PubMed ID: 9619899 [TBL] [Abstract][Full Text] [Related]
7. [Progress on genetic susceptibility to ankylosing spondylitis]. Chen RW; Wang Y; Sun SH; Duan SW Yi Chuan Xue Bao; 2005 Oct; 32(10):1108-14. PubMed ID: 16252708 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population. Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254 [TBL] [Abstract][Full Text] [Related]
9. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Rubin LA; Amos CI; Wade JA; Martin JR; Bale SJ; Little AH; Gladman DD; Bonney GE; Rubenstein JD; Siminovitch KA Arthritis Rheum; 1994 Aug; 37(8):1212-20. PubMed ID: 8053961 [TBL] [Abstract][Full Text] [Related]
11. Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia. Jönsson EG; Dahl ML; Roh HK; Jerling M; Sedvall GC Psychiatr Genet; 1998; 8(1):25-8. PubMed ID: 9564684 [TBL] [Abstract][Full Text] [Related]
12. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors. Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538 [TBL] [Abstract][Full Text] [Related]
13. Genetic studies in familial ankylosing spondylitis susceptibility. Zhang G; Luo J; Bruckel J; Weisman MA; Schumacher HR; Khan MA; Inman RD; Mahowald M; Maksymowych WP; Martin TM; Yu DT; Stone M; Rosenbaum JT; Newman P; Lee J; McClain JA; West OC; Jin L; Reveille JD Arthritis Rheum; 2004 Jul; 50(7):2246-54. PubMed ID: 15248224 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity. Neafsey P; Ginsberg G; Hattis D; Sonawane B J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526 [TBL] [Abstract][Full Text] [Related]
15. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Laval SH; Timms A; Edwards S; Bradbury L; Brophy S; Milicic A; Rubin L; Siminovitch KA; Weeks DE; Calin A; Wordsworth BP; Brown MA Am J Hum Genet; 2001 Apr; 68(4):918-26. PubMed ID: 11231900 [TBL] [Abstract][Full Text] [Related]
16. Association of the HLA-B27 antigen and the CTLA4 gene CT60/rs3087243 polymorphism with ankylosing spondylitis in Algerian population: A case-control study. Dahmani CA; Benzaoui A; Amroun H; Mecabih F; Sediki FZ; Zemani-Fodil F; Fodil M; Boughrara W; Mecheti B; Attal N; Mehtar N; Petit-Teixeira E; Boudjema A Int J Immunogenet; 2018 Jun; 45(3):109-117. PubMed ID: 29675891 [TBL] [Abstract][Full Text] [Related]
17. Is disease severity in ankylosing spondylitis genetically determined? Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700 [TBL] [Abstract][Full Text] [Related]
18. CYP2D6 polymorphism and Parkinson's disease susceptibility. Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice JM; Destée A; Agid Y; Broly F Mov Disord; 1999 Mar; 14(2):230-6. PubMed ID: 10091614 [TBL] [Abstract][Full Text] [Related]
19. HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population. Pimentel-Santos FM; Matos M; Ligeiro D; Mourão AF; Ribeiro C; Costa J; Santos H; Barcelos A; Pinto P; Cruz M; Sousa E; Santos RA; Fonseca JE; Trindade H; Guedes-Pinto H; Branco JC; Tissue Antigens; 2013 Dec; 82(6):374-9. PubMed ID: 24498993 [TBL] [Abstract][Full Text] [Related]
20. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Milicic A; Lindheimer F; Laval S; Rudwaleit M; Ackerman H; Wordsworth P; Hohler T; Brown MA Genes Immun; 2000 Oct; 1(7):418-22. PubMed ID: 11196671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]